[1]
Marchetti , M. et al. 2021. COST-EFFECTIVENESS OF POST-AUTOTRANSPLANT LENALIDOMIDE IN PERSONS WITH MULTIPLE MYELOMA. Mediterranean Journal of Hematology and Infectious Diseases. 13, 1 (Apr. 2021), Page e2021034. DOI:https://doi.org/10.4084/MJHID.2021.034.